Drug Combinations to Enhance Sensitivity and Circumvent Resistance
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
批准号:
10038085
负责人:
Jeffrey Wallace Tyner
金额:
$37.93万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2022-08-31
关键词:
AdministratorAgreementAutomobile DrivingBudgetsCollaborationsCommunicationCommunitiesDataDrug CombinationsDrug resistanceEnsureEvaluationIntellectual PropertyLeadershipOffice of Administrative ManagementPerformancePoliciesPreparationProgress ReportsRecommendationResearchResistanceResource SharingScientific EvaluationSpecimenTimeTimeLineTraveldata resourcedata sharingdrug sensitivitymeetingsoperationtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT – Administrative Core
The Administrative Core will provide leadership, scientific oversight, governance, and administrative support to
our Drug Combinations to Circumvent Resistance-Drug Resistance and Sensitivity Center (D2CR-DRSC) to
ensure effective operations, communication, internal and external collaborations, compliance and rigorous
scientific evaluation of D2CR-DRSC projects. Co-PD/Contact PI Jeffrey Tyner and Co-PD/PI Brian Druker will
serve as Co-Leaders of the Administrative Core and will be supported by a Scientific Operations Leader,
Cristina Tognon; a Collaborations Manager, Pierrette Lo; and a Research and Finance Administrator, Sarah
Bowden. The Specific Aims of the Administrative Core are to: 1) provide scientific and administrative
leadership, governance, and support to the D2CR-DRSC to ensure effective integration of all projects,
evaluation of center progress, sharing of specimens and data, and internal communication and operational
performance, and 2) provide scientific and administrative leadership to optimize the D2CR-DRSC’s
communication and collaborations with the Drug Resistance and Sensitivity Network to ensure productive
participation in cross-DRSC, NCI activities and the research community. To achieve these aims, the
Administrative Core will establish and implement D2CR-DRSC governance, including establishing an Internal
Advisory Group and an External Advisory Board to help evaluate the Center’s progress toward its aims and
milestones; develop and follow policy to ensure timely release and sharing of specimens and data; plan regular
strategic interactions and meetings; develop communications plans; ensure budget oversight and compliance;
manage intellectual property issues; complete annual progress reports; facilitate communication, collaboration
and data and resource sharing with the NCI, the DRSC Steering Committee, and the four other DRSCs in the
Network; and perform all other administrative duties required to support the D2CR-DRSC and its successful
participation in the Drug Resistance and Sensitivity Network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10038080
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
-
批准号:10684105
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:10494402
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
-
批准号:10517760
-
项目类别:
-
资助金额:$36.95万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Core A: Administrative Core
-
批准号:10684102
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:10249170
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:9985235
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:9985230
-
项目类别:
-
资助金额:$6.38万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
-
批准号:9444902
-
项目类别:
-
资助金额:$72.78万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Core A: Administrative Core
-
批准号:10517758
-
项目类别:
-
资助金额:$7.01万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Administrative Core
-
批准号:10249167
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2017
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8997484
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:9213359
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8670455
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
-
批准号:8828622
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2014
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8544411
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8715697
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8526776
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2012
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:8126307
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2010
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
-
批准号:7952615
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2010
-
负责人:Jeffrey Wallace Tyner
-
依托单位:
海外基金